# Turning Genomic Insights into Breakthrough Therapies | Peter Campbell, CSO of Quotient Therapeutics

Page: https://stenobird.com/podcast/nucleate-podcast-6322042/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics
Text version: https://stenobird.com/podcast/nucleate-podcast-6322042/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics.md
Podcast: [Nucleate Podcast](https://stenobird.com/podcast/nucleate-podcast-6322042)
Published: 2025-05-28T10:00:00+00:00
Episode link: https://nucleate-signal.simplecast.com/episodes/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics-FVozM2mz
Audio file: https://cdn.simplecast.com/audio/6a0defb6-ad56-4c08-b015-fea36f1c159f/episodes/7b922ce3-8ba5-4508-8802-faef9d73fa3d/audio/e94a85ff-d2a5-49d4-9c4c-8f1468528bf9/default_tc.mp3?aid=rss_feed&feed=OdcQl6Pu
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics
Duration seconds: 4764

## Resource

In this episode of the Nucleate Podcast, Dr Peter Campbell traces his scientific journey from a medical student in New Zealand to a pioneering genomics researcher and startup founder. Initially struggling with traditional medical training, Campbell discovered his passion for computational biology while working at the Sanger Institute, where he was instrumental in early cancer genome sequencing efforts. His research evolved from exploring cancer mutations to investigating genetic changes in normal tissues, revealing an unexpected and complex landscape of cellular evolution. This work caught the attention of Flagship Pioneering, leading to the creation of Quotient Therapeutics, a company focused on understanding how somatic mutations drive disease processes and potentially enable personalized medical treatments. Campbell discusses the platform's approach to identifying meaningful mutations, their potential therapeutic applications, and the partnership with Pfizer in cardiovascular and renal disease research. Throughout the conversation, he candidly compares the differences between academic and startup environments, emphasizing the importance of collaboration, efficiency, and storytelling. The episode provides a compelling narrative of scientific discovery, entrepreneurship, and the potential of genomics to transform our understanding of human health and disease.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/nucleate-podcast-6322042/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.